Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03801902 |
|---|---|
| Brief Title: | Accelerated Hypofractionated or Conventionally Fractionated Radiotherapy and Durvalumab in Treating Patients With Stage II-III Non-small Cell Lung Cancer |
| First Submitted : | January 11, 2019 |
| First Submitted that Met QC Criteria : | January 11, 2019 |
| First Posted : | January 14, 2019 |
| Last Update Submitted that Met QC Criteria : | January 10, 2023 |
| Last Update Posted : | January 11, 2023 |